Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. (2014) A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia). clinicaltrials.gov., Report No.: NCT01226459.
https://clinicaltrials.gov/ct2/show/NCT01226459

has been cited by the following article:

• TITLE: Efficacy and Safety of a Botanical Topical Serum on Male and Female Androgenetic Alopecia

  AUTHORS: Ferial Fanian, Pauline Meunier, Diana Bumbea, Karima Dahel, Philippe Humbert

  KEYWORDS: Hair Regrowth, Androgenic Alopecia, Botanical

  JOURNAL NAME: Journal of Cosmetics, Dermatological Sciences and Applications, Vol.12 No.1, March 25, 2022

  ABSTRACT: Androgenetic alopecia (AGA) is a common form of hair loss in both men and women, it affects up to 80% of men and 50% of women during their life. The current treatments approved for AGA are limited, inconstantly effective and might be associated with adverse events. The aim of this study was to evaluate the efficacy and safety of a botanical topical serum (SERUM THICKER) applied for 6 months in 14 males and 10 females with mild to moderate androgenetic alopecia. The hair parameters were assessed using trichoscopy images obtained with high resolution camera FotoFinder Leviacam® and analyzed with optimized software from TrichoLABTM and Vitual tattooTM technology. Hair loss was assessed using a wash-test procedure, and self-assessments were collected via questionnaires. Both at 28 days and 168 days, a significant increase of the hair density was observed, respectively +4.8% (p = 0.038); +11.7% (p